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els and sputum smear burden (P-value =0.54). There was an
association of TB severity score with lower levels of Vitamin D (P-
value =0.043). The general social functioning (SF)-12 health survey
scoring at enrolment in two arms did not differ signiﬁcantly (P-
value =0.786). However two months later ﬁndings indicate that
25-hydroxyvitamin D treatment had a positive effect on progress-
ing health-related quality of life (P-value =0.019) in each subscale
of physical health score (P-value =0.028) and mental health score
(P-value =0.025).
Conclusion: Our ﬁndings indicated that high dose cholecal-
ciferol supplementation can lead to improve clinical outcome in
tuberculouspatients especially inpatientswith calcidiol deﬁciency.
Tuberculosis alleviate quality of life and necessary at TB clinics to
apply strategies to improve the health-related quality of life of TB
patients. Therefore, we recommend vitamin D supplement therapy
for this purpose.
http://dx.doi.org/10.1016/j.ijid.2016.02.842
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Background: Mycobacterium tuberculosis (M.tb) survives inside
themacrophages bymanipulating thehost immune responses.Mtb
cell-wall associated glycoproteins play an important role in initia-
tion of host-pathogen interactions.
Methods & Materials: M.smegmatis mc2155 was used in this
study. Cloning and expression was performed in pSMT3 shuttle
vector. Invasion assay in HeLa cells. Survival assay, autopahgy,
oxidative stress response, immunostaining by ﬂuroscence micro-
scope and Western blot analysis was done in mouse macrophages.
Microbial adhesion to hydrocarbons (MATH) testwas performed to
assess bacterial hydrophocity. Bacterial susceptibility against cell
wall acting antibiotics was done with CFU (Colony Forming Unit)
assay.
Results: To identify novel Mtb glycoproteins, we employed a
multi-lectin system to capture glycoproteins from puriﬁed Mtb
cell wall and identiﬁed them by mass spectrometry analysis. A
novel protein as putative acetyltransferase (ACTase)was identiﬁed.
Recombinant M.smegmatis expressing the ACTase (MsmACTase)
showed increased invasion in human epithelial cells and survival
in mouse macrophages. Increased intracellular bacillary burden
was a result of inhibition of autophagy and ROS production due
to reduced expression of superoxide dismutase (SOD) and catalase
enzymes in Msm ACTase infected macrophages when compared
with wild-type and vector control (pSMT3) strains. Subsequent
studies showed that decreased ROS production was due to over
expression of ROS scavenging peroxisomal membrane protein 70
(PMP70) . MsmACTase showed increased expression of acylCoA
oxidase (ACOX-1), a classical marker enzyme for peroxiosmal
-fatty acid oxidation. MsmACTase also exhibited increased pro-
duction of nitric oxide and expression of inducible nitric oxide
synthase (iNOS) in infected macrophages. Moreover, MsmACTase
showed increased resistance to cell wall acting anti-TB drugs and
to lysozyme due to the increased cell surface hydrophobicity.
Conclusion: We have shown that acetyltransferase gene
(ACTase) of Mtb expressed in M.smegmatis aid intracellular
mycobacterial survival through inhibition of autophagy and oxida-
tive stress responses inmacrophages. The present study reports for
the ﬁrst time thatMsm ACTase scavengesH2O2 due to over expres-
sion of ROS scavengingperoxisomalmembraneprotein 70 (PMP70)
with which insights a new mechanism how the pathogen surpass
the host defense in Mtb infection. The above ﬁndings may lead to
identiﬁcation of a potential drug target for the antimycobacterial
therapy.
http://dx.doi.org/10.1016/j.ijid.2016.02.843
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Background: To describe the overall direct medical costs and
the compensation from health insurance systems and the TB con-
trol projects, andanalyze theeconomicburden for thewhole course
of treatment of pulmonary tuberculosis (PTB) patients in Shanghai.
Methods & Materials: The copy of invoices during the course
of TB diagnosis and treatment of 766 newly registered PTB patients
from 2013 were collected in four districts in Shanghai, meanwhile
these patients were investigated by questionnaire. Descriptive
analysis and ranksum test were employed.
Results: Themedians (inter-quartile range) of 766 PTB patients’
direct medical costs for whole course of treatment were 5757.4
(3749.87, 12632.98) yuan/person. All patients had an out-patient
cost with a median of 4605.3 (3490.8, 6335.2) yuan/person, con-
sisted of the cost of western medicine (47.6%), Chinese patent
drugs (19.9%), laboratory test fee (18.1%), inspection fee (12.1%)
and treatment/registered fee (2.3%). Among the western medicine
fee, hepatoprotectants accounted for 57.1%, followed by the ﬁrst-
line anti-TB drugs (20.2%) and second-line anti-TB drug (11.1%);
a higher proportion of hepatoprotectants in Chinese patent drugs,
reached 60.8%; in laboratory test fee, costs of liver function tests
(36.2%) and tuberculosis determination (31.5%) were relatively
higher; inspection fee was mostly CT cost, accounting for 82.9%.
The amount of cost was related to the District, age, the location
of household register, health insurance types, the level of medical
institutions, categoryof PTB. Themedianof theproportionof health
